newsfilter
← Latest News
PR Newswire·

/R E P E A T -- Braxia Scientific Awarded Government of Canada Funding to Complete First of its Kind Ketamine Clinical Trial for Bipolar Depression/

Fully funded by the Canadian Institute of Health Research (CIHR), this multi-site clinical trial will take place at Toronto's University Health Network (UHN) and Braxia's CRTCE Research Clinic Largest study of its kind with IV Ketamine to be conducted